期刊文献+

人神经生长因子信号肽介导β-内啡肽的分泌表达

Signal Peptide from Human Nerve Growth Factor Mediated Secretory Expression of β-endorphin
下载PDF
导出
摘要 目的:构建人神经生长因子信号肽与人β-内啡肽融合基因的真核表达载体,研究人神经生长因子信号肽介导β-内啡肽的分泌表达。方法:取得人基因组后,PCR法获取人的神经生长因子信号肽部分序列及人β-内啡肽序列;通过SOE—PCR法将两段DNA序列连接,然后插入到真核表达载体内,测序正确后扩增转染级的真核表达载体。表达载体脂质体法转染NIH3T3细胞,转染后48—72h收集细胞及培养上清,RT—PCR法检测融合基因的转录,RIA法测定细胞外β-内啡肽的浓度。结果:成功构建全人源的分泌型表达β-内啡肽的真核表达载体,DNA序列经测序完全符合实验设计;融合基因能够顺利地得到转录并进行表达翻译,在细胞培养上清中可检测到其产物。结论:构建的真核表达载体能够分泌表达人β-内啡肽,提示人神经生长因子信号肽序列能够发挥其介导蛋白产物分泌表达的作用。 Objective: To construct the eukaryotic vector expressing the fusion gene generated with the signal pepfide from human nerve growth factor and human β- endorphin, and to study its secretory expression mediated by the signal peptide from human nerve growth factor. Methods: After human geneme DNA obtained, the signal peptide sequence from human nerve growth factor and human β-endorphin were got respectively by PCR. The whole fragment, constructed by hgation of these above two fragments by SOE- PCR, was subcloned into the eukaryofic vector. The generated vector was upscaled to produce transfection- grade vector after it was sequenced right. NIH3T3 cells were transfected by produced vectors according to the manual of Lipofectamine2000. The transcfipted RNA of fusion gene was detected by RT- PCR and the endorphin concentration in cell culture media was measured by RIA between 48 to 72 hours after transfecfion. Results: The eukaryofic vector secretorily expressing human beta- endorphin was successfully constructed. The DNA sequence accorded with the designed sequence completely. The fusion gene was successfully transcripted and expressed. The expression product was detected in the cell culture media. Conclusion: The constructed eukaryofic vector can secretorily express human beta- endorphin. The selected signal peptide from human nerve growth factor can mediate the exeeytosis of expression product.
出处 《生物技术》 CAS CSCD 2008年第1期21-23,共3页 Biotechnology
关键词 神经生长因子 分泌型表达 Β-内啡肽 nerve growth factor secretory expression β- endorphin
  • 相关文献

参考文献9

  • 1Finegold A. A., Mannes A J, Iadarola M J, et al. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain [J]. Human Gene Therapy,1999,5(10):3211-3216.
  • 2尤圣武,徐学武,俞卫锋,于布为,钱其军,苏长青,王星华.鞘内注射入β-内啡肽基因重组腺病毒对慢性神经病理痛大鼠的镇痛作用[J].中华麻醉学杂志,2005,25(6):428-432. 被引量:6
  • 3Knappskog S, Ravneberg H, Gjerdrum C, et al. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide[J] .J Biotechnol, 2007, 128(4):705 - 15.
  • 4Ravn P, Arnau J, Madsen S M, et al. Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis [ J ]. Microbiology, 2003, 149(Pt 8) : 2193 - 2201.
  • 5Serruto D, Galeotti C L. The signal peptide sequence of a lyric transglycosylase of Neissefia meningifidis is involved in regulation of gene expression[J]. Microbiology, 2004, 150(Pt 5): 1427-1437.
  • 6Holden P, Keene D R, Lunstrum G P, et al. Secretion of cartilage oligomerle matrix protein is affected by the signal peptide[J] .J Biol Chem, 2005, 280(17) : 17172 - 17179.
  • 7Knappskog S, Ravneberg H, Gjerdrum C, et al. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide[J] .J Biotechnol, 2007, 128(4) :705 -715.
  • 8Millington W R, Smith D L. The posttranslational processing of beta - endorphin in human hypothalamus[J]. J Neurochem, 1991, 57(3) :775 - 81.
  • 9M Hosaka, M Nagahama, WS Kim, etal. Arg-X- Lys/Arg- Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway[J].J. Biol. Chem., 1991, 266(19):12127-12130.

二级参考文献11

  • 1尤圣武 ,俞卫锋 ,于布为 ,钱其军 ,王星华 ,苏长青 ,曹云飞 ,杨立群 ,李晓青 .重组小鼠神经生长因子前导肽和人β-内啡肽融合基因非增殖型腺病毒的构建和鉴定[J].中华麻醉学杂志,2004,24(12):896-900. 被引量:6
  • 2徐晓军,郝景霞.神经源性疼痛的动物模型[J].中国疼痛医学杂志,1995,1(2):112-119. 被引量:13
  • 3Lin CR, Yang LC, Lee TH, et al. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther, 2002, 9:1247-1253.
  • 4Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain.Hum Gene Ther, 1999, 5:3211-3216.
  • 5Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 3: 87-107.
  • 6Milligan ED, Hinde JL, Mehmert KK, et al. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods, 1999, 90:81-86.
  • 7Yao MZ, Gu JF, Wang JH, et al. Adenovirus-mediated interleukin-2 gene therapy of nociception. Gene Ther, 2003,10:1392-1399.
  • 8Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988,32:77-88.
  • 9Samuelsson H, Ekman R, Hedner T. CSF neuropeptides in cancer pain:effects of spinal opioid therapy. Acta Anaesthesiol Scand, 1993, 37:502-508.
  • 10Driesse MJ, Kros JM, Avezaat CJ, et al. Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates. Hum Gene Ther, 1999,10:2347-2354.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部